Simon Quick Advisors, LLC Amgen Inc Transaction History

Simon Quick Advisors, LLC

$1.57 Billion
Q3 2024

A detailed history of Simon Quick Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Simon Quick Advisors, LLC holds 3,147 shares of AMGN stock, worth $892,520. This represents 0.06% of its overall portfolio holdings.

Number of Shares

3,147

Previous 2,882 9.2%

Holding current value

$892,520

Previous $900,000 12.56%

% of portfolio

0.06%

Previous 0.06%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$309.38 - $337.38 $81,985 - $89,405	265 Added 9.2%	3,147 $1.01 Million
Q2 2024 Aug 02, 2024	BUY	$262.75 - $319.31 $136,892 - $166,360	521 Added 22.07%	2,882 $900,000
Q1 2024 Apr 19, 2024	BUY	$268.87 - $324.56 $51,891 - $62,640	193 Added 8.9%	2,361 $671,000
Q4 2023 Jan 16, 2024	BUY	$255.7 - $288.46 $30,172 - $34,038	118 Added 5.76%	2,168 $624,000
Q3 2023 Oct 24, 2023	BUY	$218.65 - $271.46 $65,595 - $81,438	300 Added 17.14%	2,050 $550,000
Q2 2023 Aug 01, 2023	BUY	$214.27 - $253.37 $47,353 - $55,994	221 Added 14.45%	1,750 $388,000
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $81,961 - $99,897	363 Added 31.13%	1,529 $369,000
Q4 2022 Jan 30, 2023	BUY	$229.03 - $291.01 $267,048 - $339,317	1,166 New	1,166 $306,000
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $1,988 - $2,276	-10 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$233.58 - $259.14 $32,934 - $36,538	-141 Reduced 93.38%	10 $2,000
Q1 2021 May 06, 2021	SELL	$221.91 - $258.6 $10,873 - $12,671	-49 Reduced 24.5%	151 $37,000
Q4 2020 Jan 27, 2021	SELL	$216.38 - $257.67 $43,492 - $51,791	-201 Reduced 50.12%	200 $46,000
Q3 2020 Oct 26, 2020	BUY	$234.65 - $260.95 $53,500 - $59,496	228 Added 131.79%	401 $102,000
Q2 2020 Aug 04, 2020	SELL	$197.81 - $242.74 $26,902 - $33,012	-136 Reduced 44.01%	173 $41,000
Q1 2020 Apr 09, 2020	BUY	$182.24 - $241.7 $911 - $1,208	5 Added 1.64%	309 $63,000
Q4 2019 Jan 06, 2020	BUY	$189.21 - $243.2 $57,519 - $73,932	304 New	304 $73,000
Q3 2019 Oct 16, 2019	SELL	$174.11 - $208.62 $2,785 - $3,337	-16 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$166.7 - $195.41 $2,667 - $3,126	16 New	16 $0
Q1 2019 Apr 16, 2019	SELL	$180.87 - $203.88 $27,853 - $31,397	-154 Closed	0 $0
Q4 2018 Jan 29, 2019	BUY	$178.4 - $208.25 $24,084 - $28,113	135 Added 710.53%	154 $30,000
Q3 2018 Oct 29, 2018	SELL	$185.29 - $208.89 $8,338 - $9,400	-45 Reduced 70.31%	19 $4,000
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $7,472 - $8,392	45 Added 236.84%	64 $11,000
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $33,589 - $37,529	-199 Reduced 91.28%	19 $4,000
Q3 2017 Nov 06, 2017	BUY	$167.29 - $191.0 $3,011 - $3,438	18 Added 9.0%	218 $41,000
Q2 2017 Aug 11, 2017	BUY	N/A	200	200 $34,000

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simon Quick Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simon Quick Advisors, LLC with notifications on news.

Account

Simon Quick Advisors, LLC Amgen Inc Transaction History